SRR1478032
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- SPERMATOGENESIS+0.301
- KRAS_SIGNALING_DN+0.267
- HEDGEHOG_SIGNALING+0.248
- PANCREAS_BETA_CELLS+0.058
- APICAL_SURFACE-0.019
- WNT_BETA_CATENIN_SIGNALING-0.033
- ESTROGEN_RESPONSE_EARLY-0.064
- UV_RESPONSE_DN-0.074
- MYOGENESIS-0.118
- ESTROGEN_RESPONSE_LATE-0.137
Top 10 suppressed
- MYC_TARGETS_V1-0.630
- MTORC1_SIGNALING-0.505
- ANDROGEN_RESPONSE-0.467
- REACTIVE_OXYGEN_SPECIES_PATHWAY-0.458
- PROTEIN_SECRETION-0.449
- OXIDATIVE_PHOSPHORYLATION-0.447
- ANGIOGENESIS-0.442
- UNFOLDED_PROTEIN_RESPONSE-0.442
- MYC_TARGETS_V2-0.441
- DNA_REPAIR-0.430
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
8 twins match this tumor's tissue · 2 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1334717 | GTEX | — | 0.966 |
| 2 | BS_90B22NGP | ATRT | — | 0.963 |
| 3 | SRR1432343 | GTEX | — | 0.961 |
| 4 | SRR1466850 | GTEX | — | 0.957 |
| 5 | SRR1406561 | GTEX | — | 0.954 |
| 6 | SRR1336379 | GTEX | — | 0.954 |
| 7 | BS_3P20Q2C3 | low-grade glioma | — | 0.952 |
| 8 | SRR1323130 | GTEX | — | 0.950 |
| 9 | SRR4195666 | — | — | 0.949 |
| 10 | ERR4976613 | — | D | 0.949 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 4 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| SPERMATOGENESIS | 0.301 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.267 | Remibrutinib | — uncovered |
| HEDGEHOG_SIGNALING | 0.248 | Inavolisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.058 | Cobimetinib | — uncovered |